What top creators are saying about Zentalis Pharmaceuticals, Inc.(ZNTL)

Biopharmaceutical company developing cancer treatments, including a WEE1 inhibitor.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Zentalis Pharmaceuticals, Inc. in the last 30 days yet.

Top creators covering Zentalis Pharmaceuticals, Inc. (ZNTL)

The 1 sources with the most insights about Zentalis Pharmaceuticals, Inc. on Kazuha.

Latest insights about Zentalis Pharmaceuticals, Inc. (ZNTL)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Tuesday, September 29, 2026

Neutral

The host mentioned its WEE1 inhibitor program for platinum-resistant ovarian cancer but was unsure about the company's plans and offered no view on its prospects.

Discussed alongside Zentalis Pharmaceuticals, Inc. (ZNTL)

Other assets that creators frequently mention in the same content as Zentalis Pharmaceuticals, Inc..

Frequently asked

Which podcasters and creators cover Zentalis Pharmaceuticals, Inc. (ZNTL) the most?

The most active sources covering Zentalis Pharmaceuticals, Inc. (ZNTL) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Zentalis Pharmaceuticals, Inc. (ZNTL) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Zentalis Pharmaceuticals, Inc. (ZNTL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Zentalis Pharmaceuticals, Inc. (ZNTL)?

Creators covering Zentalis Pharmaceuticals, Inc. (ZNTL) most frequently also discuss ASML, 000660, CCL, TXN, AAOI. See the "Discussed alongside" section above for full asset pages.